The San Francisco-based venture capital firm, founded in 2014 by Jenny Rooke, focuses on funding entrepreneurs and companies that are developing new tools and technologies in research tools, molecular diagnostics, synthetic biology, and industrial biology. They invest in seed-stage, early-stage, and later-stage companies in healthcare, life sciences, big data, artificial intelligence, machine learning, and agricultural technology sectors. Genoa Ventures aims to bridge the gap for visionary startups that struggle to raise capital from traditional funders because they are multi-disciplinary and market-making, and don't fit most VC’s patterns and boxes. They combine an appetite for technology-driven, “category-defying” opportunities in life sciences with domain expertise and operational experience to select and nurture the best bio-based companies early, before most other investors.